This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogel, F. R.
Right arrow Articles by Sarver, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogel, F. R.
Right arrow Articles by Sarver, N.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 07 1995, 406-410, Vol 8, No. 3
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Nucleic acid vaccines

FR Vogel and N Sarver
Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.

The use of nucleic acid-based vaccines is a novel approach to immunization that elicits immune responses similar to those induced by live, attenuated vaccines. Administration of nucleic acid vaccines results in the endogenous generation of viral proteins with native conformation, glycosylation profiles, and other posttranslational modifications that mimic antigen produced during natural viral infection. Nucleic acid vaccines have been shown to elicit both antibody and cytotoxic T-lymphocyte responses to diverse protein antigens. Advantages of nucleic acid-based vaccines include the simplicity of the vector, the ease of delivery, the duration of expression, and, to date, the lack of evidence of integration. Further studies are needed to assess the feasibility, safety, and efficacy of this new and promising technology.


This article has been cited by other articles:

  • Bosarge, J. R., Watt, J. M., McDaniel, D. O., Swiatlo, E., McDaniel, L. S. (2001). Genetic Immunization with the Region Encoding the {alpha}-Helical Domain of PspA Elicits Protective Immunity against Streptococcus pneumoniae. Infect. Immun. 69: 5456-5463 [Abstract] [Full Text]  
  • Steele, K. E., Stabler, K., VanderZanden, L. (2001). Cutaneous DNA Vaccination Against Ebola Virus by Particle Bombardment: Histopathology and Alteration of CD3-positive Dendritic Epidermal Cells. Vet Pathol 38: 203-215 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»